10,000 Steps a Day: What the Research Shows and What It Can't Prove

The 10,000-step goal traces to a 1960s Japanese pedometer, not to a medical finding. A 2025 Lancet Public Health meta-analysis links more daily steps to lower risk of death and several diseases, with benefits slowing at roughly 5,000 to 8,000 steps, but the evidence is observational and cannot prove cause.

Walking 10,000 steps a day is associated with a lower risk of death and several diseases, but the number itself is not a scientific threshold. The largest recent synthesis of the evidence, published in The Lancet Public Health in July 2025, found that risk falls steadily as daily steps rise. The steepest gains come at low counts, and the curve slows somewhere around 5,000 to 8,000 steps, depending on the outcome and the age group.

The distinction matters because the target shapes the habits of millions of people who wear trackers, and it is usually described in two opposite and equally flawed ways: as a proven medical goal or as a myth. The evidence supports neither description. The studies are observational, so they show that people who walk more tend to have lower risk, not that adding steps produces the lower risk.

A marketing name, not a medical finding

Dr. I-Min Lee of Harvard traced the number to 1965, when a Japanese company sold a device called the Manpo-kei, which translates as "10,000 steps meter." In an interview with Harvard Health, she said: "The name was a marketing tool." A Popular Science article by a physical-activity researcher identifies the company as Yamasa Clock and says the benchmark was not based on scientific evidence.

Most popular accounts repeat the same origin story, which traces back to Lee's work, so the web sources are not independent confirmations of one another. They also disagree on timing. One blog quotes the original ad copy as saying "Since the Tokyo Olympics, there has been a growing movement for national fitness," which places the campaign after the 1964 Games. A page from the UK's Men's Health Forum says the idea was part of a pedometer campaign ahead of those Games. Both are secondary sources, so the safest description is a mid-1960s campaign around the time of the Tokyo Olympics.

One further claim, in an Esquire Philippines article, holds that science was brought in only in the late 1970s, when a researcher used pedometers, treadmills and walking groups to arrive at 10,000. That account rests on a single source and could not be traced to primary material, so it should be treated as unconfirmed.

What the best evidence shows

The most comprehensive synthesis found is a systematic review and dose-response meta-analysis led by Prof. Ding Ding (Melody Ding) of the University of Sydney, published July 23, 2025, in The Lancet Public Health. The review included 57 studies from 35 cohorts, and the meta-analyses drew on 31 studies from 24 cohorts. Participants were adults, mainly in high-income countries, and the studies used device-measured steps.

Everything in the analysis is measured against a reference of 2,000 steps per day. Compared with that very low level, 7,000 steps was associated with reduced risk ranging from 6% for cancer incidence to 47% for all-cause mortality. At 10,000 steps, the range was 10% lower cancer incidence up to 48% lower all-cause mortality. At 12,000 steps, the maximum modeled reduction ran from 12% for cancer incidence to 55% for all-cause mortality. Estimates stop at 12,000 because data beyond that are scarce.

The table shows why the headline figures need context. Several rows rest on only two to four studies, and the cancer incidence interval (0.87–1.01) includes 1, meaning that result is not statistically significant. The paper also reports heterogeneity, a measure of how much studies disagree, ranging from 0% for dementia to 78.2% for cardiovascular mortality. A high figure means the pooled estimate hides considerable variation between studies.

How certain are the findings?

According to a summary of the abstract on the Mindd Foundation site, the certainty of evidence under the GRADE system was moderate for all outcomes except cardiovascular mortality (low), cancer incidence (low), physical function (low) and falls (very low). Because that comes from a secondary site, it is worth checking against the paper itself. The authors list their own limitations: few studies for most outcomes, no age-specific analysis, and biases in the individual studies, including residual confounding.

Where the gains level off

In the 2025 analysis, the overall decrease in risk was attenuated before reaching 7,000 steps per day. For all-cause mortality, cardiovascular disease incidence, dementia and falls, the association was non-linear, with inflection points around 5,000 to 7,000 steps. In plain terms, the curve bends there and the added benefit per step shrinks.

Other outcomes behaved differently. Cardiovascular mortality, cancer incidence, cancer mortality, type 2 diabetes and depressive symptoms showed inverse linear associations, meaning no clear plateau appeared within the range studied. That does not prove benefits continue indefinitely, since the data stop at 12,000 steps, but it complicates any single cutoff.

Is 10,000 better than 7,000?

In a post-hoc comparison, 10,000 steps was associated with about 10% lower all-cause mortality than 7,000 steps. The post-hoc analysis also found that step counts above 7,000 were associated with lower risk of all-cause mortality, cardiovascular disease incidence, cancer mortality, dementia and depressive symptoms. The authors, however, described the incremental improvement beyond 7,000 steps as small, and reported no statistical difference between 7,000 steps and a higher count for the other outcomes.

The authors' interpretation is that 10,000 steps can still be a viable target for people who are more active, while 7,000 steps is associated with clinically meaningful improvements and might be a more realistic target for some. Co-author Dr. Katherine Owen said in a University of Sydney release: "For people who are already active, 10,000 steps a day is great," but beyond 7,000 steps the extra benefits for most outcomes were modest. Press coverage that says 7,000 is simply as good as 10,000 overstates the plateau, and coverage that dismisses the difference ignores the 10% figure the paper reports.

Age changes the picture

An earlier meta-analysis by the Steps for Health Collaborative, led by Amanda Paluch and published in The Lancet Public Health in 2022, pooled 15 studies (seven published, eight unpublished). It covered 47,471 adults and 3,013 deaths, with a median follow-up of 7.1 years. The median daily steps in its four quartiles were 3,553, 5,801, 7,842 and 10,901.

That analysis found mortality risk plateaued at roughly 6,000 to 8,000 steps for adults 60 and over, and at roughly 8,000 to 10,000 steps for adults under 60. A 2019 study in JAMA Internal Medicine led by Lee found that 4,400 steps in older women lowered death risk, and that the benefit tapered off at around 7,500, according to Lee's own account in Popular Science. The primary paper was not retrieved for this article, so its sample size and follow-up are not reported here.

Other work points the same way. A Men's Health Forum summary of 2022 analyses by Borja del Pozo Cruz and Matthew Ahmadi reports that every 2,000 steps lowered the risk of premature death by 8% to 11%, up to roughly 10,000 steps a day. A 2023 meta-analysis in the European Journal of Preventive Cardiology covered 17 studies and over 226,000 generally healthy people, with benefits seen at as few as about 4,000 steps, as summarized by a private health site. Both are secondary summaries. A 2024 umbrella review found that an increase of 500 to 1,000 steps per day was associated with lower all-cause mortality and cardiovascular events.

The plateau estimates differ partly because the studies divide groups differently. The 2025 authors acknowledge they had no age-specific analysis, so the 5,000-to-7,000 range for all adults cannot simply be compared with the age-split ranges from 2022. These syntheses also draw on overlapping cohorts, so their agreement is not the same as fully independent confirmation.

Pace, and how well steps are counted

Does walking speed matter?

The evidence on pace is mixed. In a press release, Paluch said the 2022 analysis found no definitive association with walking speed beyond total steps. The paper's abstract adds nuance: after adjusting for total steps, the link with a higher stepping rate was weaker but still significant for a peak 30-minute cadence (hazard ratio 0.67, 95% CI 0.56–0.83).

The 2025 authors say the relationship between cadence, a proxy for stepping rate or intensity, and health outcomes is less consistent. A Sydney researcher quoted by the Men's Health Forum said faster walking added benefit. Whether pace matters beyond the total count remains unresolved.

Step counts are an imperfect measurement

Every threshold above depends on devices that do not agree. A 2024 comparison study cites earlier work reporting that step counts from 13 consumer and research-grade wearables varied by about 2,500 steps, even when worn at the same time by one person. That figure is background material in the study and was not independently checked.

Slow walking is a particular weak point. A 2017 validation paper reports that the ActiGraph GT3X+ underestimated steps by about 40% at 0.9 meters per second and by 60% at 0.67 meters per second. That matters most for older adults, who may walk slowly. A perspective paper adds that wearable step counts can be misleading and are not necessarily equal to the actual steps a person takes.

The studies also used different devices and wear sites, which adds noise and possible bias. The practical consequence is that thresholds such as 7,000 or 8,000 should be read as approximate ranges, not exact lines.

What the studies cannot prove

The core limitation is design. The evidence is mainly from prospective observational cohorts, which cannot rule out confounding. Healthier, wealthier or more mobile people may walk more for reasons that also protect their health, and the authors acknowledge residual confounding. No randomized trial of steps with hard outcomes such as death or heart attack turned up in the research for this article.

The trials that do exist test something narrower. A meta-analysis of community-based randomized trials concluded that step-count monitoring leads to short- and long-term increases in steps. That shows trackers can raise activity, but it does not show that the extra steps reduce disease or death.

Three other cautions apply. First, the comparison point of 2,000 steps is very low, so the gain from 7,000 versus 2,000 is not the gain an average adult would get from moving from 6,000 to 7,000. Second, the papers report relative reductions, and the absolute number of deaths avoided depends on baseline risk, which the retrieved material does not give. Third, participants came mainly from high-income countries, and age-specific results are limited.

No study in the research showed harm from higher step counts, but data above about 12,000 steps are sparse. In expert reaction collected by the Science Media Centre, one expert said increasing to 10,000 steps seems to confer no negative effects, while others said the specific number should not get too much reverence. The first remark is a comment, not a tested safety finding.

What it means for an ordinary walker

Step targets can be loosely connected to activity guidelines, though only as context. One Taiwanese study found that 30 minutes of moderate-to-vigorous activity equated to about 8,602 steps per day for older men and 8,940 for older women. A Spanish study put the equivalent at roughly 7,000 to 10,000 steps when added to habitual activity. Estimates vary by population, and neither figure is an official equivalence.

Read together, the research suggests that 10,000 steps is neither a myth nor a threshold. It is a point on a curve whose steepest part lies at much lower counts, and whose flattening depends on the outcome and the walker's age. For someone averaging very few steps, the data point to meaningful gains from modest increases. For someone already active, 10,000 remains associated with slightly lower risk for some outcomes.

The open questions are the ones that would change advice: trials linking step increases to hard outcomes, age-specific curves, the role of pace, and what happens past 12,000 steps. Until then, the number on a tracker is best treated as a rough guide to how much a person moves, not a pass-or-fail grade. This article offers research context, not personal medical advice.

Frequently asked questions

Is 10,000 steps a day necessary for good health?

The research does not show that 10,000 is necessary. The 2025 Lancet Public Health meta-analysis found risk fell before 7,000 steps for many outcomes, and its authors called 7,000 a possibly more realistic target for some people. Ten thousand remained associated with slightly lower risk for some outcomes, such as about 10% lower all-cause mortality than 7,000.

Where did the 10,000-step goal come from?

Harvard's Dr. I-Min Lee traced it to 1965, when a Japanese company marketed a pedometer called the Manpo-kei, or "10,000 steps meter." She said the name was a marketing tool. Sources differ on whether the campaign came before or after the 1964 Tokyo Olympics, so mid-1960s is the safest description.

How many steps a day are linked to a lower risk of death?

In the 2025 meta-analysis, 7,000 steps per day was associated with 47% lower all-cause mortality than 2,000 steps, and 10,000 steps with 48% lower. These are relative reductions from observational studies, not proof that walking caused them. Earlier work reported plateaus at roughly 6,000 to 8,000 steps for adults 60 and over and 8,000 to 10,000 for younger adults.

Does walking faster matter more than step count?

This is unsettled. The 2022 analysis's lead author said there was no definitive association with speed beyond total steps, yet its abstract found a weaker but significant link for peak 30-minute cadence. The 2025 authors describe the cadence evidence as less consistent.

Are fitness trackers accurate enough to follow a step goal?

Only roughly. A 2024 study cites earlier work finding that 13 wearables varied by about 2,500 steps when worn together by one person. Slow walking can also be undercounted, with one 2017 validation paper reporting underestimates of about 40% to 60% for one device at slow speeds.

Sources

1. Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis , The Lancet Public Health (2025-07-23)
2. Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis (abstract) , DOAJ
3. Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis (abstract) , Nutrition Evidence Database
4. Walking 7000 Steps Per Day Reduces Risk of Chronic Diseases, Cognitive Decline , HCPLive
5. Research summary: Daily steps and health outcomes in adults , Mindd Foundation
6. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts , The Lancet Public Health
7. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts , PubMed Central
8. Meta-analysis of 15 studies reports new findings on how many daily walking steps needed for longevity benefit , EurekAlert
9. Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts (PDF) , Academia.edu
10. 10,000 steps a day — or fewer? , Harvard Health Publishing
11. Why 10,000 steps a day isn't the secret to better health , Popular Science
12. Walking: science confirms 10,000 steps a day , Men's Health Forum
13. The Origin of the 10,000 Steps a Day , Jacked Nerds (Substack)
14. The 10000 Steps Goal Is Actually an Ad Campaign for a Japanese Pedometer , Esquire Philippines
15. Rethink the 10000 a day step goal, study suggests , The University of Sydney (2025-07-24)
16. 7000 steps a day cuts death risk by 47%—and that might be all you need , ScienceDaily
17. How Many Steps a Day to Reduce CVD and CV Death? , American College of Cardiology (2025-07-30)
18. Expert reaction to systematic review and meta-analysis of daily step count and risk of chronic diseases, cognitive decline and death , Science Media Centre (2025-07-23)
19. Reflections on daily steps and health outcomes , The Lancet Public Health
20. New Study: 10,000 steps is not the magical number , Private Health (PHM)
21. Objectively measured daily steps and health outcomes: an umbrella review of the systematic review and meta-analysis of observational studies , PubMed Central
22. The effects of step-count monitoring interventions on physical activity: systematic review and meta-analysis of community-based randomised controlled trials in adults , PubMed Central
23. Comparison of step-count outcomes across seven different activity trackers: a free-living experiment with young and older adults , PubMed Central
24. Validation of the ADAMO Care Watch for step counting in older adults , PLOS ONE
25. Digital technologies for step counting: between promises of reliability and risks of reductionism , PubMed Central
26. Goal setting for WHO guideline adherence: accelerometer steps/day translation of moderate-to-vigorous physical activity in older adults , PubMed Central
27. Limitations of Daily Step Count for Assessing Health in Older Adults: The Need to Consider Walking Intensity , PubMed Central

This article was drafted with the help of AI and reviewed by Jaroha editors before publication.